EMA Turns Down Minoryx’s Orphan Drug Nezglyal & Apellis’ Syfovre, OKs Three Others

 
• By Eliza Slawther
  
Thumb up and thumb down
• Source: Shutterstock

More from Approvals

More from Product Reviews